Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $84.3100 (-2.27%) ($84.1300 - $86.7900) on Mon. Oct. 19, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.23% (three month average) | RSI | 43 | Latest Price | $84.3100(-2.27%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.9% a day on average for past five trading days. | Weekly Trend | ABBV declines -0.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(48%) SPLV(37%) VYM(35%) DIA(33%) XLP(33%) | Factors Impacting ABBV price | ABBV will decline at least -0.615% in a week (0% probabilities). VIXM(-24%) UUP(-8%) VXX(-6%) EDOC(-4%) TLT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.615% (StdDev 1.23%) | Hourly BBV | -1.8 () | Intraday Trend | -2.6% | | | |
|
Resistance Level | $86.82 | 5 Day Moving Average | $85.94(-1.9%) | 10 Day Moving Average | $86.56(-2.6%) | 20 Day Moving Average | $86.82(-2.89%) | To recent high | -15.3% | To recent low | 0% | Market Cap | $148.747b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |